CUSIP 68403P203COM NEWORMPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
54 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 3.17M | $9.03M | 0 | Held |
| 2 | Aquamarine Financial (Cayman) Ltd | 1.97M | $5.62M | 0 | Held |
| 3 | Sb Capital Management Inc | 1.90M | $5.42M | +1.90M | New Position |
| 4 | Murchinson Ltd. | 1.34M | $3.82M |
| −411.3K |
| Reduced |
| 5 | Boothbay Fund Management, LLC | 612.2K | $1.74M | −233.2K | Reduced |
| 6 | Marshall Wace, LLP | 259.1K | $738.3K | +259.1K | New |
| 7 | Rathbones Group PLC | 233.0K | $664.1K | 0 | Held |
| 8 | Citadel Advisors LLC | 196.0K | $558.7K | +84.3K | Added |
| 9 | Dimensional Fund Advisors LP | 150.5K | $428.8K | +3.0K | Added |
| 10 | Renaissance Technologies LLC | 147.5K | $420.4K | −1.4K | Reduced |
See every fund holding Oramed Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders